Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Bastida JM, Malvestiti S, Boeckelmann D, Palma-Barqueros V, Wolter M, Lozano ML, Glonnegger H, Benito R, Zaninetti C, Sobotta F, Schilling FH, Morgan NV, Freson K, Rivera J, Zieger B. A Novel GATA1 Variant in the C-Terminal Zinc Finger Compared with the Platelet Phenotype of Patients with A Likely Pathogenic Variant in the N-Terminal Zinc Finger. Cells. 2022 Oct 14;11(20):3223. doi: 10.3390/cells11203223. PubMed PMID: 36291092; PubMed Central PMCID: PMC9600848.
AÑO: 2022; IF: 7.666
36291092
Triguero A, Xicoy B, Zamora L, Jimenez MJ, Garcia O, Calabuig M, Diaz-Beya M, Arzuaga J, Ramos F, Medina A, Bernal T, Talarn C, Coll R, Collado R, Chen TH, Borras J, Brunet S, Marchante I, Marco V, Lopez-Cadenas F, Calbacho M, Simiele A, Cortes M, Cedena MT, Pedreno M, Aguilar C, Pedro C, Fernandez M, Stoica C, Ribera JM, Sanz G. Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria. Leuk Res. 2022 May;116:106836. doi: 10.1016/j.leukres.2022.106836. Epub 2022 Mar 26. PubMed PMID: 35405632.
AÑO: 2022; IF: 2.7
35405632
Lozano Almela M.L., Sanz Alonso M.Á., Vicente García V. Reply. Medicina Clinica. 10 June 2022. 158:e2-e3. 10.1016/j.medcli.2021.09.029
AÑO: 2022; IF: 3.9
34893333
Valenti V, Jimenez-Fonseca P, Msaouel P, Salazar R, Carmona-Bayonas A. Fooled by Randomness. The Misleading Effect of Treatment Crossover in Randomized Trials of Therapies with Marginal Treatment Benefit. Cancer Invest. 2022 Feb;40(2):184-188. doi: 10.1080/07357907.2021.2020281. Epub 2021 Dec 27. PubMed PMID: 34919008.
AÑO: 2022; IF: 2.4
34919008
Bravo-Perez C, Toderici M, Chambers JE, Martinez-Menarguez JA, Garrido-Rodriguez P, Perez-Sanchez H, de la Morena-Barrio B, Padilla J, Minano A, Cifuentes-Riquelme R, Vicente V, Lozano ML, Marciniak SJ, de la Morena-Barrio ME, Corral J. Full-length antithrombin frameshift variant with aberrant C-terminus causes endoplasmic reticulum retention with a dominant-negative effect. JCI Insight. 2022 Oct 10;7(19):e161430. doi: 10.1172/jci.insight.161430. PubMed PMID: 36214221; PubMed Central PMCID: PMC9675572.
AÑO: 2022; IF: 9.484
36214221
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL